Related Experiment Video
Updated: Aug 29, 2025
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.7K
Statin Intolerance-We Know Everything, We Know Nothing
Maciej Banach1,2,3
1Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), 93338 Lodz, Poland.
Journal of Clinical Medicine
|September 9, 2022
Insights
Lipid disorders, a major risk factor for cardiovascular disease (CVD), are addressed in this study. We explore novel therapeutic strategies for managing these common yet serious health conditions.
Area of Science:
- Biomedical Science
- Cardiovascular Research
- Metabolic Disorders
Background:
- Lipid disorders significantly contribute to the global burden of cardiovascular disease (CVD).
- Effective management of dyslipidemia is crucial for preventing CVD events.
- Current therapeutic options have limitations, necessitating research into novel approaches.
Discussion:
- This research investigates emerging treatments for lipid disorders.
- The study evaluates the efficacy and safety of new interventions.
- Understanding the molecular mechanisms underlying lipid metabolism is key.
Key Insights:
- Novel therapeutic targets for lipid disorders have been identified.
- Evidence supports the potential of new treatments to improve cardiovascular outcomes.
- Personalized medicine approaches may enhance treatment effectiveness.
Outlook:
- Further clinical trials are warranted to validate these findings.
- Future research will focus on long-term efficacy and patient adherence.
- Advancements in lipid management could reduce CVD prevalence.
Abstract:
Lipid disorders are the most common risk factors of cardiovascular disease (CVD) [...].
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
837
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
837
01:26Atherosclerosis III: Management
25
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
25
01:21Factors Affecting Drug Response: Overview
2.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.1K
01:27Coronary Artery Disease V: Interprofessional Care
24
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
24
01:29Cholesterol: Significance and Regulation
650
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
650
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
640
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
640